BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salade L, Wauthoz N, Deleu M, Vermeersch M, De Vriese C, Amighi K, Goole J. Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia. Int J Nanomedicine 2017;12:8531-43. [PMID: 29238190 DOI: 10.2147/IJN.S147650] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Baig MH, Ahmad K, Moon JS, Park S, Ho Lim J, Chun HJ, Qadri AF, Hwang YC, Jan AT, Ahmad SS, Ali S, Shaikh S, Lee EJ, Choi I. Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies. Front Physiol 2022;13:876078. [DOI: 10.3389/fphys.2022.876078] [Reference Citation Analysis]
2 Tai J, Han M, Lee D, Park I, Lee SH, Kim TH. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 2022;14:1073. [DOI: 10.3390/pharmaceutics14051073] [Reference Citation Analysis]
3 Zambom CR, da Fonseca FH, Crusca E Jr, da Silva PB, Pavan FR, Chorilli M, Garrido SS. A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans. Front Microbiol 2019;10:1667. [PMID: 31417503 DOI: 10.3389/fmicb.2019.01667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Perkušić M, Nižić Nodilo L, Ugrina I, Špoljarić D, Jakobušić Brala C, Pepić I, Lovrić J, Matijašić G, Gretić M, Zadravec D, Kalogjera L, Hafner A. Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery. Int J Pharm 2022;624:122038. [PMID: 35870666 DOI: 10.1016/j.ijpharm.2022.122038] [Reference Citation Analysis]
5 Barros C, Aranha N, Severino P, Souto EB, Zielińska A, Lopes A, Rios A, Batain F, Crescencio K, Chaud M, Alves T. Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration. Pharmaceutics 2021;13:686. [PMID: 34068793 DOI: 10.3390/pharmaceutics13050686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 T de Barros C, Rios AC, Alves TFR, Batain F, Crescencio KMM, Lopes LJ, Zielińska A, Severino P, G Mazzola P, Souto EB, Chaud MV. Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery. Int J Mol Sci 2020;21:E5974. [PMID: 32825177 DOI: 10.3390/ijms21175974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Knauer N, Pashkina E, Apartsin E. Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins. Pharmaceutics 2019;11:E91. [PMID: 30795556 DOI: 10.3390/pharmaceutics11020091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Yoo SH, Kim HW, Lee JH. Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives. J Tissue Eng 2022;13:20417314221083414. [PMID: 35340424 DOI: 10.1177/20417314221083414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Curcio M, Cirillo G, Rouaen JRC, Saletta F, Nicoletta FP, Vittorio O, Iemma F. Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective. Pharmaceutics 2020;12:E1183. [PMID: 33291284 DOI: 10.3390/pharmaceutics12121183] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hong SS, Oh KT, Choi HG, Lim SJ. Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives. Pharmaceutics 2019;11:E540. [PMID: 31627301 DOI: 10.3390/pharmaceutics11100540] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
11 Rinaldi F, Hanieh PN, Chan LKN, Angeloni L, Passeri D, Rossi M, Wang JT, Imbriano A, Carafa M, Marianecci C. Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery. Pharmaceutics 2018;10:E38. [PMID: 29565809 DOI: 10.3390/pharmaceutics10020038] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
12 Sibinovska N, Žakelj S, Trontelj J, Kristan K. Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations. Pharmaceutics 2022;14:369. [DOI: 10.3390/pharmaceutics14020369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nižić Nodilo L, Ugrina I, Špoljarić D, Amidžić Klarić D, Jakobušić Brala C, Perkušić M, Pepić I, Lovrić J, Saršon V, Safundžić Kučuk M, Zadravec D, Kalogjera L, Hafner A. A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies. Pharmaceutics 2021;13:795. [PMID: 34073500 DOI: 10.3390/pharmaceutics13060795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Reis Zambom C, Henrique da Fonseca F, Santesso Garrido S. Bio- and Nanotechnology as the Key for Clinical Application of Salivary Peptide Histatin: A Necessary Advance. Microorganisms 2020;8:E1024. [PMID: 32664360 DOI: 10.3390/microorganisms8071024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zha S, Wong KL, All AH. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Adv Healthc Mater 2022;11:e2102610. [PMID: 35166052 DOI: 10.1002/adhm.202102610] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sonvico F, Clementino A, Buttini F, Colombo G, Pescina S, Stanisçuaski Guterres S, Raffin Pohlmann A, Nicoli S. Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 2018;10:E34. [PMID: 29543755 DOI: 10.3390/pharmaceutics10010034] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 26.5] [Reference Citation Analysis]
17 Jain H, Prabhakar B, Shende P. Modulation of olfactory area for effective transportation of actives in CNS disorders. Journal of Drug Delivery Science and Technology 2022;68:103091. [DOI: 10.1016/j.jddst.2021.103091] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alexander A, Agrawal M, Uddin A, Siddique S, Shehata AM, Shaker MA, Ata Ur Rahman S, Abdul MIM, Shaker MA. Recent expansions of novel strategies towards the drug targeting into the brain. Int J Nanomedicine 2019;14:5895-909. [PMID: 31440051 DOI: 10.2147/IJN.S210876] [Cited by in Crossref: 42] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
19 Cortés H, Alcalá-Alcalá S, Caballero-Florán IH, Bernal-Chávez SA, Ávalos-Fuentes A, González-Torres M, González-Del Carmen M, Figueroa-González G, Reyes-Hernández OD, Floran B, Del Prado-Audelo ML, Leyva-Gómez G. A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier. Membranes (Basel) 2020;10:E212. [PMID: 32872576 DOI: 10.3390/membranes10090212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]